CSL LIMITED - Announcements

Market Cap $133.1B Add to my watchlist

Healthcare Biotechnology

Montu is a fully licensed medical cannabis company with a clear focus on the Australian... Montu is a fully licensed medical cannabis company with a clear focus on the Australian and New Zealand market. While the company offers its own medicinal-grade cannabis and cannabis-based medicines under the Circle brand, Montu's primary focus is making it easier for patients to access these crucial treatments.More

RCE'S BREAKTHROUGH

Recce Pharmaceuticals (ASX:RCE) is stepping up its trial activities in Australia’s nearest Asian neighbour, Indonesia. Recce’s flagship anti-infective, R327, can be applied as a gel – and this gel-based version of the drug has been of specific interest...

Announcements

Filter Results

All Price Sensitive Only

CSL	Notification regarding unquoted securities - CSL		27/08/21	27.65KB	Share
CSL	Notification regarding unquoted securities - CSL		27/08/21	25.42KB	Share
CSL	Change of Director's Interest Notice		24/08/21	199.44KB	Share
CSL	Initial Director's Interest Notice		18/08/21	148.66KB	Share
CSL	Initial Director's Interest Notice		18/08/21	151.26KB	Share
CSL	Notification of cessation of securities - CSL		18/08/21	21.47KB	Share
CSL	CSL Results Presentation	PRICE SENSITIVE	18/08/21	2.54MB	Share
CSL	CSL Results Announcement	PRICE SENSITIVE	18/08/21	426.28KB	Share
CSL	Dividend/Distribution - CSL		18/08/21	24.94KB	Share
CSL	CSL Statutory Accounts for the Full Year Ended 30 June 2021	PRICE SENSITIVE	18/08/21	2.79MB	Share
CSL	Appointment of New Non-executive Director		17/08/21	121.55KB	Share
CSL	Application for quotation of securities - CSL		13/07/21	24.76KB	Share
CSL	Notification regarding unquoted securities - CSL		06/07/21	24.39KB	Share
CSL	Application for quotation of securities - CSL		02/07/21	24.75KB	Share
CSL	Final Director's Interest Notice		01/07/21	176.67KB	Share
CSL	Notification of cessation of securities - CSL		01/07/21	21.47KB	Share
CSL	Resignation of Director		25/06/21	130.81KB	Share
CSL	Application for quotation of securities - CSL		24/06/21	24.77KB	Share
CSL	Notification of cessation of securities - CSL		22/06/21	21.43KB	Share
CSL	Appointment of New Non-Executive Director		16/06/21	120.39KB	Share
CSL	Appendix 2A		19/05/21	269.71KB	Share
CSL	Update on CSL Agreement with uniQure	PRICE SENSITIVE	06/05/21	117.89KB	Share
CSL	Presentation at Macquarie Australia Conference 2021		05/05/21	1.7MB	Share
CSL	Appendix 2A		22/04/21	269.72KB	Share
CSL	Appendix 3G		06/04/21	326.48KB	Share
CSL	Update - Dividend/Distribution - CSL		09/03/21	25.2KB	Share
CSL	Appendix 2A		05/03/21	269.84KB	Share
CSL	Appendix 3G		05/03/21	270.49KB	Share
CSL	Change of Director's Interest Notices		26/02/21	302.38KB	Share
CSL	Appendix 2A		26/02/21	269.48KB	Share
CSL	Half Year Results Investor Presentation	PRICE SENSITIVE	18/02/21	2.64MB	Share
CSL	Half Year Results Announcement	PRICE SENSITIVE	18/02/21	257.68KB	Share
CSL	Dividend/Distribution - CSL	PRICE SENSITIVE	18/02/21	24.76KB	Share
CSL	Statutory Accounts for the Half Year Ended 31 Dec 2020	PRICE SENSITIVE	18/02/21	827.94KB	Share
CSL	Notice of Half Year Results Briefing 2021		15/02/21	139.14KB	Share
CSL	Appendix 2A		12/02/21	268.95KB	Share
CSL	Final Director's Interest Notice		01/02/21	176.59KB	Share
CSL	Resignation of Director		27/01/21	131.27KB	Share
CSL	Change of Director's Interest Notice		04/01/21	321.68KB	Share
CSL	Update on UQ-CSL v451 COVID-19 Vaccine	PRICE SENSITIVE	11/12/20	121.88KB	Share
CSL	New Vaccine Manufacturing Facility		16/11/20	146.56KB	Share
CSL	Appendix 2A		11/11/20	269.31KB	Share
CSL	CSLs Annual R&D Investor Briefing 2020		20/10/20	9.22MB	Share
CSL	Notice of Research & Development Investor Briefing		19/10/20	111.51KB	Share
CSL	Appendix 3G		16/10/20	271.85KB	Share
CSL	Change of Director's Interest Notice		16/10/20	201.74KB	Share
CSL	Final Director's Interest Notice		16/10/20	177KB	Share
CSL	Appendix 2A		14/10/20	269.32KB	Share
CSL	CSL 2020 AGM Poll Results		14/10/20	196.13KB	Share
CSL	Chairman's Address to Shareholders	PRICE SENSITIVE	14/10/20	3.63MB	Share
CSL	Appendix 2A		08/10/20	256.93KB	Share
CSL	CSL Supply Agreement for UQ Vaccine with Commonwealth	PRICE SENSITIVE	08/10/20	148.37KB	Share
CSL	Joy Linton named as Chief Financial Officer		01/10/20	120.27KB	Share
CSL	Appendix 2A		29/09/20	257.26KB	Share
CSL	Appendix 2A		23/09/20	257.28KB	Share
CSL	Change of Director's Interest Notice		23/09/20	209.56KB	Share
CSL	Update - Dividend/Distribution - CSL		14/09/20	25.2KB	Share
CSL	Appendix 2A		11/09/20	262.72KB	Share
CSL	Appendix 3G		11/09/20	265.35KB	Share
CSL	Change of Director's Interest Notice		11/09/20	201.91KB	Share
CSL	Appendix 2A		07/09/20	262.9KB	Share
CSL	Appendix 3G		07/09/20	266.35KB	Share
CSL	Agreements to Manufacture COVID-19 Vaccines		07/09/20	172.38KB	Share
CSL	Shareholder Pack 2020		04/09/20	840.13KB	Share
CSL	Appendix 4G		04/09/20	161.7KB	Share
CSL	Notice of Annual General Meeting		04/09/20	1.09MB	Share
CSL	Annual Report to shareholders		04/09/20	5.52MB	Share
CSL	Change of Director's Interest Notice		02/09/20	204KB	Share
CSL	Change of Director's Interest Notice		02/09/20	191.42KB	Share
CSL	Appendix 2A		02/09/20	262.92KB	Share
CSL	Change of Director's Interest Notice		28/08/20	298.32KB	Share
CSL	Change of Director's Interest Notice		28/08/20	418.88KB	Share
CSL	Appendix 3G		28/08/20	270.09KB	Share
CSL	Appendix 2A		27/08/20	262.6KB	Share
CSL	Appendix 2A		21/08/20	262.64KB	Share
CSL	Initial Director's Interest Notice		19/08/20	122.21KB	Share
CSL	CSL Results Presentation	PRICE SENSITIVE	19/08/20	3.07MB	Share
CSL	Dividend/Distribution - CSL		19/08/20	24.78KB	Share
CSL	CSL Results Announcement	PRICE SENSITIVE	19/08/20	406.12KB	Share
CSL	Statutory Accounts for the Full Year Ended 30 June 2020	PRICE SENSITIVE	19/08/20	7.14MB	Share
CSL	ASX Notice of Full Year Results Briefing 2020		11/08/20	112.33KB	Share
CSL	CSL Appoints New Non Executive Director		16/07/20	130.84KB	Share
CSL	CSL to acquire LateStage Gene Therapy Candidate from uniQure	PRICE SENSITIVE	25/06/20	154.71KB	Share
CSL	Change in Leadership of CSL's Finance Function	PRICE SENSITIVE	17/06/20	115.6KB	Share
CSL	CSL to Acquire Biotech Company Vitaeris		09/06/20	124.97KB	Share
CSL	CEPI CSL UQ Media Release partnering agreement		05/06/20	266.74KB	Share
CSL	ASA Presentation		29/05/20	2.64MB	Share
CSL	CSL's Strategic Partnership with Thermo Fisher Scientific		27/05/20	122.91KB	Share
CSL	New Debt Facilities to Strengthen Maturity Profile	PRICE SENSITIVE	07/05/20	181.86KB	Share
CSL	Company Update on COVID-19		09/04/20	1.4MB	Share
CSL	Company Update on COVID-19		08/04/20	110.81KB	Share
CSL	Change of Director's Interest Notice		24/03/20	209.24KB	Share
CSL	Change of Director's Interest Notice		17/03/20	201.55KB	Share
CSL	Update - Dividend/Distribution - CSL		13/03/20	25.2KB	Share
CSL	Appendix 2A		13/03/20	265.47KB	Share
CSL	Change of Director's Interest Notice		12/03/20	297.12KB	Share
CSL	Appendix 2A		06/03/20	265.33KB	Share
CSL	Appendix 2A		06/03/20	265.3KB	Share
CSL	Appendix 3G		06/03/20	270.4KB	Share
CSL	Appendix 2A		06/03/20	265.45KB	Share

CSL Notification regarding unquoted securities - CSL
27/08/21		27.65KB	Share
CSL Notification regarding unquoted securities - CSL
27/08/21		25.42KB	Share
CSL Change of Director's Interest Notice
24/08/21		199.44KB	Share
CSL Initial Director's Interest Notice
18/08/21		148.66KB	Share
CSL Initial Director's Interest Notice
18/08/21		151.26KB	Share
CSL Notification of cessation of securities - CSL
18/08/21		21.47KB	Share
CSL CSL Results Presentation
18/08/21	PRICE SENSITIVE	2.54MB	Share
CSL CSL Results Announcement
18/08/21	PRICE SENSITIVE	426.28KB	Share
CSL Dividend/Distribution - CSL
18/08/21		24.94KB	Share
CSL CSL Statutory Accounts for the Full Year Ended 30 June 2021
18/08/21	PRICE SENSITIVE	2.79MB	Share
CSL Appointment of New Non-executive Director
17/08/21		121.55KB	Share
CSL Application for quotation of securities - CSL
13/07/21		24.76KB	Share
CSL Notification regarding unquoted securities - CSL
06/07/21		24.39KB	Share
CSL Application for quotation of securities - CSL
02/07/21		24.75KB	Share
CSL Final Director's Interest Notice
01/07/21		176.67KB	Share
CSL Notification of cessation of securities - CSL
01/07/21		21.47KB	Share
CSL Resignation of Director
25/06/21		130.81KB	Share
CSL Application for quotation of securities - CSL
24/06/21		24.77KB	Share
CSL Notification of cessation of securities - CSL
22/06/21		21.43KB	Share
CSL Appointment of New Non-Executive Director
16/06/21		120.39KB	Share
CSL Appendix 2A
19/05/21		269.71KB	Share
CSL Update on CSL Agreement with uniQure
06/05/21	PRICE SENSITIVE	117.89KB	Share
CSL Presentation at Macquarie Australia Conference 2021
05/05/21		1.7MB	Share
CSL Appendix 2A
22/04/21		269.72KB	Share
CSL Appendix 3G
06/04/21		326.48KB	Share
CSL Update - Dividend/Distribution - CSL
09/03/21		25.2KB	Share
CSL Appendix 2A
05/03/21		269.84KB	Share
CSL Appendix 3G
05/03/21		270.49KB	Share
CSL Change of Director's Interest Notices
26/02/21		302.38KB	Share
CSL Appendix 2A
26/02/21		269.48KB	Share
CSL Half Year Results Investor Presentation
18/02/21	PRICE SENSITIVE	2.64MB	Share
CSL Half Year Results Announcement
18/02/21	PRICE SENSITIVE	257.68KB	Share
CSL Dividend/Distribution - CSL
18/02/21	PRICE SENSITIVE	24.76KB	Share
CSL Statutory Accounts for the Half Year Ended 31 Dec 2020
18/02/21	PRICE SENSITIVE	827.94KB	Share
CSL Notice of Half Year Results Briefing 2021
15/02/21		139.14KB	Share
CSL Appendix 2A
12/02/21		268.95KB	Share
CSL Final Director's Interest Notice
01/02/21		176.59KB	Share
CSL Resignation of Director
27/01/21		131.27KB	Share
CSL Change of Director's Interest Notice
04/01/21		321.68KB	Share
CSL Update on UQ-CSL v451 COVID-19 Vaccine
11/12/20	PRICE SENSITIVE	121.88KB	Share
CSL New Vaccine Manufacturing Facility
16/11/20		146.56KB	Share
CSL Appendix 2A
11/11/20		269.31KB	Share
CSL CSLs Annual R&D Investor Briefing 2020
20/10/20		9.22MB	Share
CSL Notice of Research & Development Investor Briefing
19/10/20		111.51KB	Share
CSL Appendix 3G
16/10/20		271.85KB	Share
CSL Change of Director's Interest Notice
16/10/20		201.74KB	Share
CSL Final Director's Interest Notice
16/10/20		177KB	Share
CSL Appendix 2A
14/10/20		269.32KB	Share
CSL CSL 2020 AGM Poll Results
14/10/20		196.13KB	Share
CSL Chairman's Address to Shareholders
14/10/20	PRICE SENSITIVE	3.63MB	Share
CSL Appendix 2A
08/10/20		256.93KB	Share
CSL CSL Supply Agreement for UQ Vaccine with Commonwealth
08/10/20	PRICE SENSITIVE	148.37KB	Share
CSL Joy Linton named as Chief Financial Officer
01/10/20		120.27KB	Share
CSL Appendix 2A
29/09/20		257.26KB	Share
CSL Appendix 2A
23/09/20		257.28KB	Share
CSL Change of Director's Interest Notice
23/09/20		209.56KB	Share
CSL Update - Dividend/Distribution - CSL
14/09/20		25.2KB	Share
CSL Appendix 2A
11/09/20		262.72KB	Share
CSL Appendix 3G
11/09/20		265.35KB	Share
CSL Change of Director's Interest Notice
11/09/20		201.91KB	Share
CSL Appendix 2A
07/09/20		262.9KB	Share
CSL Appendix 3G
07/09/20		266.35KB	Share
CSL Agreements to Manufacture COVID-19 Vaccines
07/09/20		172.38KB	Share
CSL Shareholder Pack 2020
04/09/20		840.13KB	Share
CSL Appendix 4G
04/09/20		161.7KB	Share
CSL Notice of Annual General Meeting
04/09/20		1.09MB	Share
CSL Annual Report to shareholders
04/09/20		5.52MB	Share
CSL Change of Director's Interest Notice
02/09/20		204KB	Share
CSL Change of Director's Interest Notice
02/09/20		191.42KB	Share
CSL Appendix 2A
02/09/20		262.92KB	Share
CSL Change of Director's Interest Notice
28/08/20		298.32KB	Share
CSL Change of Director's Interest Notice
28/08/20		418.88KB	Share
CSL Appendix 3G
28/08/20		270.09KB	Share
CSL Appendix 2A
27/08/20		262.6KB	Share
CSL Appendix 2A
21/08/20		262.64KB	Share
CSL Initial Director's Interest Notice
19/08/20		122.21KB	Share
CSL CSL Results Presentation
19/08/20	PRICE SENSITIVE	3.07MB	Share
CSL Dividend/Distribution - CSL
19/08/20		24.78KB	Share
CSL CSL Results Announcement
19/08/20	PRICE SENSITIVE	406.12KB	Share
CSL Statutory Accounts for the Full Year Ended 30 June 2020
19/08/20	PRICE SENSITIVE	7.14MB	Share
CSL ASX Notice of Full Year Results Briefing 2020
11/08/20		112.33KB	Share
CSL CSL Appoints New Non Executive Director
16/07/20		130.84KB	Share
CSL CSL to acquire LateStage Gene Therapy Candidate from uniQure
25/06/20	PRICE SENSITIVE	154.71KB	Share
CSL Change in Leadership of CSL's Finance Function
17/06/20	PRICE SENSITIVE	115.6KB	Share
CSL CSL to Acquire Biotech Company Vitaeris
09/06/20		124.97KB	Share
CSL CEPI CSL UQ Media Release partnering agreement
05/06/20		266.74KB	Share
CSL ASA Presentation
29/05/20		2.64MB	Share
CSL CSL's Strategic Partnership with Thermo Fisher Scientific
27/05/20		122.91KB	Share
CSL New Debt Facilities to Strengthen Maturity Profile
07/05/20	PRICE SENSITIVE	181.86KB	Share
CSL Company Update on COVID-19
09/04/20		1.4MB	Share
CSL Company Update on COVID-19
08/04/20		110.81KB	Share
CSL Change of Director's Interest Notice
24/03/20		209.24KB	Share
CSL Change of Director's Interest Notice
17/03/20		201.55KB	Share
CSL Update - Dividend/Distribution - CSL
13/03/20		25.2KB	Share
CSL Appendix 2A
13/03/20		265.47KB	Share
CSL Change of Director's Interest Notice
12/03/20		297.12KB	Share
CSL Appendix 2A
06/03/20		265.33KB	Share
CSL Appendix 2A
06/03/20		265.3KB	Share
CSL Appendix 3G
06/03/20		270.4KB	Share
CSL Appendix 2A
06/03/20		265.45KB	Share

REFRESH

First 2 3 4 5 6

(20min delay)
Last $275.50		Change -0.300(0.11%)		Mkt cap ! $133.1B

Open	High	Low	Value	Volume
$276.76	$277.00	$275.36	$128.2M	465.0K

Buyers (Bids)

No.	Vol.	Price($)
1	100	$275.30

Sellers (Offers)

Price($)	Vol.	No.
$275.68	189	1

View Market Depth

No.	Vol.	Price($)
1	100	275.300
2	1040	275.100
11	2892	275.000
1	3	274.950
1	1020	274.940

Price($)	Vol.	No.
275.680	189	1
275.750	562	1
275.830	447	1
275.850	5000	1
275.980	1020	1

Last trade - 16.10pm 06/05/2024 (20 minute delay)


Last $275.43		Change -0.300 ( 0.30 %)
Open	High	Low	Volume
$276.39	$277.00	$275.39	183080
Last updated 15.59pm 06/05/2024 ?

CSL (ASX) Chart

CSL LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories